143 related articles for article (PubMed ID: 8616757)
1. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
[TBL] [Abstract][Full Text] [Related]
2. A different profile of epitopic dominance in the immunoglobulin G response to bovine betalactoglobulin in lung cancer.
Michils A; Casimir G; Yernault JC; Gossart B; Duchateau J
Cancer; 1993 Dec; 72(12):3607-13. PubMed ID: 8252475
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer-related changing profile of B-cell epitopes recognized on mucosal antigens: the Der p1 model.
Michils A; Yernault JC; El Chaarani B; Van Laethem JL; Crockaert F; Gossart B; Duchateau J
Cancer; 1995 Oct; 76(7):1166-75. PubMed ID: 8630893
[TBL] [Abstract][Full Text] [Related]
4. Antibody affinity disturbance in the immunoglobulin immune response to mucosal antigenic stimulation in lung cancer. The Betalactoglobulin Model.
Michils A; el Chaarani B; Yernault JC; Servais G; Gossart B; Duchateau J
Cancer; 1993 Jan; 71(2):332-7. PubMed ID: 8422625
[TBL] [Abstract][Full Text] [Related]
5. Anti-betalactoglobulin IgG antibodies bind to a specific profile of epitopes when patients are allergic to cow's milk proteins.
Duchateau J; Michils A; Lambert J; Gossart B; Casimir G
Clin Exp Allergy; 1998 Jul; 28(7):824-33. PubMed ID: 9720816
[TBL] [Abstract][Full Text] [Related]
6. Abnormal humoral immune response to mucosal antigenic stimulation in patients with lung cancer.
Michils A; Yernault JC; Noel E; Gossart B; Servais G; Duchateau J
Cancer; 1992 May; 69(9):2252-7. PubMed ID: 1373339
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma thymosin-alpha1 levels in lung cancer patients.
Sasaki H; Fujii Y; Masaoka A; Yamakawa Y; Fukai I; Kiriyama M; Saito Y; Matsui H
Eur J Cardiothorac Surg; 1997 Dec; 12(6):885-91. PubMed ID: 9489875
[TBL] [Abstract][Full Text] [Related]
8. Mite allergy is associated with a specific profile of IgG epitopes recognized on antigen p1 of Dermatophagoides pteronyssinus.
Duchateau J; Michils A; Michel O; Baras L
Clin Exp Allergy; 1997 Mar; 27(3):296-305. PubMed ID: 9088656
[TBL] [Abstract][Full Text] [Related]
9. Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.
Schlichtholz B; Trédaniel J; Lubin R; Zalcman G; Hirsch A; Soussi T
Br J Cancer; 1994 May; 69(5):809-16. PubMed ID: 7514026
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma.
Kiers L; Altermatt HJ; Lennon VA
Mayo Clin Proc; 1991 Dec; 66(12):1209-16. PubMed ID: 1660950
[TBL] [Abstract][Full Text] [Related]
11. Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study.
Segawa Y; Kageyama M; Suzuki S; Jinno K; Takigawa N; Fujimoto N; Hotta K; Eguchi K
Br J Cancer; 1998 Sep; 78(5):667-72. PubMed ID: 9744508
[TBL] [Abstract][Full Text] [Related]
12. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
[TBL] [Abstract][Full Text] [Related]
13. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
14. Elastase levels in small and non-small cell lung carcinoma.
Güner G; Kirkali G; Baskin Y; Karlikaya C; Akkoçlu A
Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):305S. PubMed ID: 8224451
[No Abstract] [Full Text] [Related]
15. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
[TBL] [Abstract][Full Text] [Related]
16. Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227.
Shitara K; Hanai N; Yoshida H
Anticancer Res; 1993; 13(3):579-86. PubMed ID: 7686360
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-p53 autoantibodies in primary resected non-small-cell lung carcinoma.
Iizasa T; Fujisawa T; Saitoh Y; Hiroshima K; Ohwada H
Cancer Immunol Immunother; 1998 Aug; 46(6):345-9. PubMed ID: 9756419
[TBL] [Abstract][Full Text] [Related]
18. [Suitability of limited resection in lung cancer].
Nakamura H; Hiyoshi T; Katsuumi T; Hirakuri S; Taguchi M; Ikeda T; Hirano T; Sakai H; Saito M; Konaka C; Kato H
Jpn J Thorac Cardiovasc Surg; 1998 Apr; 46 Suppl():119-20. PubMed ID: 9642811
[No Abstract] [Full Text] [Related]
19. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1.
Türeci O; Mack U; Luxemburger U; Heinen H; Krummenauer F; Sester M; Sester U; Sybrecht GW; Sahin U
Cancer Lett; 2006 May; 236(1):64-71. PubMed ID: 15992994
[TBL] [Abstract][Full Text] [Related]
20. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
Hanai N; Shitara K; Yoshida H
Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
